Denali Therapeutics Inc. (DNLI) stock
DNLINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$18.00−0.08 (-0.44%)
Close on Nov 17, 2026Market cap $2.88BP/E –Yield –
Denali Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Denali Therapeutics's market cap was $3.15B on Nov 11, 2026, against $2.85B a year earlier. Over the last 5 years it ranged from $1.92B to $5.44B, with a median of $3.30B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.15B | +30.2% |
| 2025 | Dec 31, 2025 | $2.42B | -17.4% |
| 2024 | Dec 31, 2024 | $2.93B | -1.1% |
| 2023 | Dec 29, 2023 | $2.96B | -13.9% |
| 2022 | Dec 30, 2022 | $3.44B | -36.7% |
| 2021 | Dec 31, 2021 | $5.44B | -45.8% |
| 2020 | Dec 31, 2020 | $10.03B | +500.1% |
| 2019 | Dec 31, 2019 | $1.67B | -13.9% |
| 2018 | Dec 31, 2018 | $1.94B | +1832.2% |
| 2017 | Dec 29, 2017 | $100.48M | – |
See a number that looks wrong?